Sunday, November 9, 2025
7:00 PM – 7:15 PM: Registration and Dinner
7:15 PM – 8:15 PM: Symposium
New Orleans Marriott Warehouse Arts District
859 Convention Center Blvd
New Orleans, Louisiana
Meeting Room: Gravier A-C
PRESENTING FACULTY
 |
Nosheen Reza, MD, FACC, FHFSA Assistant Professor of Medicine Penn Center for Inherited Cardiovascular Disease Section of Advanced Heart Failure, Transplantation, and Mechanical Support Penn Medicine Philadelphia, Pennsylvania |
 |
Muthiah Vaduganathan, MD, MPH Co-Director Center for Cardiometabolic Implementation Science Brigham and Women’s Hospital Harvard Medical School Boston, Massachusetts |
PROGRAM OVERVIEW
In this evidence-based symposium, the program will blend research and practice tools to increase knowledge of the pathophysiologic relationship between CVD and CKD and provide evidence-based CKD screening for patients with CVD or elevated CV risk. Additionally, case studies and patient scenarios will demonstrate how to create evidence-based guideline-informed treatment plans for the use of novel therapies in patients with CVD, who may also have co-morbid CKD. The program will provide tools to apply this knowledge to practice to pursue a more holistic, patient-centered care model that streamlines communication and encourages shared decision-making.
LEARNING OBJECTIVES:
- Describe the pathophysiologic relationship between CVD and CKD and provide evidence-based CKD screening for patients with CVD or CV risk factors
- Create evidence-based guideline-informed treatment plans for the use of novel CMD therapies in patients with CVD, who may also have comorbid CKD
- Apply a holistic, patient-centric care model that streamlines communication across an MDT and includes the patient’s perspective through SDM to enhance care for patients with CVD and comorbid CKD
TARGET AUDIENCE
This educational activity is designed to meet the needs of general cardiologists and advanced practice providers (APPs) in cardiology, who play a crucial role in cardiovascular (CV) care and see patients at high risk for chronic kidney disease (CKD).
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use. For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at [email protected]
